ESC 365 - Assessing the clinical utility of prescription EPA - What do the latest data suggest?

ESC Premium Access

Assessing the clinical utility of prescription EPA - What do the latest data suggest?

Session: Residual risk for cardiovascular disease - Omega-3 fatty acids in cardiology practice

Topic: Risk Factors and Prevention, Other

Speaker: Professor W. Weintraub (Washington, DC, US)

Organised by Medscape Education, supported with an educational grant from Amarin

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor William Weintraub

Medstar Research Institute, Washington, DC (United States of America)

4 presentations

0 follower

4 more presentations in this session

Welcome and introductions

Speaker: Professor D. Bhatt (New York, US)

Omega-3 fatty acids - Why they are not all the same?

Speaker: Doctor P. Mason (Boston, US)

Omega-3s in the cardiology clinic - Practical implications and strategies to improve care

Speaker: Professor D. Bhatt (New York, US)

Panel discussion and questions and answers session

Speaker: Professor D. Bhatt (New York, US)

Access the full session

Residual risk for cardiovascular disease - Omega-3 fatty acids in cardiology practice

Speakers: Professor W. Weintraub, Professor D. Bhatt, Doctor P. Mason, Professor D. Bhatt, Professor D. Bhatt

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources